Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Vancomycin (VAN) and daptomycin (DAP) are approved as a monotherapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. A regimen of daptomycin plus ceftaroline (DAP+CPT) has shown promise in published case series of MRSA salvage therapy, but no comparative data exist to compare up-fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Geriak, Matthew, Haddad, Fadi, Rizvi, Khulood, Rose, Warren, Kullar, Ravina, LaPlante, Kerry, Yu, Marie, Vasina, Logan, Ouellette, Krista, Zervos, Marcus, Nizet, Victor, Sakoulas, George
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496065/
https://ncbi.nlm.nih.gov/pubmed/30858203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02483-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados